Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors
Eva Klopocki(University of Würzburg), Edgar Dahl(RWTH Aachen University), Guido Sauter(Universität Hamburg), Peter J. Wild(Goethe University Frankfurt), Irina Klaman, H. Leibiger, Esmeralda Castaños‐Vélez, Gad Singer(Kantonsspital Baden), Ronald Simon(Universität Hamburg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann, André Rosenthal, K. Hermann, Lutz Essers, Birgit Weber, Glen Kristiansen(University Hospital Bonn)
Cited by 174
Related Papers
Tissue microarrays for high-throughput molecular profiling of tumor specimens
|Nature Medicine|1998|4.1k
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660